Company Profile
- Official Name: AbbVie Inc.
- Founded: 2013
- Headquarters: North Chicago, Illinois, United States
- Company Type: Biopharmaceutical company
- Primary Focus: Innovative medicines
- Global Presence: Products available in more than 175 countries
About AbbVie
AbbVie is a global biopharmaceutical company focused on discovering, developing and delivering medicines for a range of serious and chronic health conditions. The company became an independent publicly traded company in 2013 following its separation from Abbott, while retaining a connection to Abbott’s long pharmaceutical heritage.
AbbVie’s portfolio and research activities cover several therapeutic areas, including immunology, oncology, neuroscience, eye care and aesthetics. The company reports that its products help treat more than 75 conditions and are available in more than 175 countries.
AbbVie maintains research, manufacturing and commercial operations across a broad international network and continues to develop medicines for significant areas of unmet medical need.
Medicine & Product Information
Major Therapeutic Areas:
Immunology, oncology, neuroscience, eye care and aesthetics.
Medicines associated with this company:
Browse AbbVie medicines in the Medicine Library database.